Equity Brief · Healthcare2026-05-20
SYK·Healthcare

Stryker Corporation

I · Análisis con IA

En breve

Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].

Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].

Stryker is financially robust with excellent margins, strong cash generation, and low leverage.

En breve AI analysisConfianza 8/10

Puntuación Sentinellis

10/10

Financially healthy

Capitalización bursátil

$121.8B

Ingresos (12 meses)

$25.1B

II · Noticias recientes

Qué movió el precio

5 stories · ranked by relevance

  • macro2026-05-18

    PAHC or SYK: Which Is the Better Value Stock Right Now?

    Yahoo Finance

  • macro2026-05-19

    BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem

    Yahoo Finance

  • macro2026-05-16

    Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback

    Simply Wall St

  • macro2026-05-15

    Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

    Yahoo Finance

  • macro2026-05-15

    Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

    Yahoo Finance

Premium · gratis con cualquier cuenta

Stryker trades at a PE ratio of 36.8x, which is elevated relative to historical norms and leaves the stock vulnerable to significant correction if earnings disappoint, especially with the next earnings report due July 30, 2026 [Yahoo Finance] [EODHD]

1 de 4 riesgos en este informe

Riesgos

4

Oportunidades

6

Señales de alerta

2

Dirección

10

21 hallazgos más en el informe completo — gratis con cualquier cuenta.

Desbloquea el análisis completo de Stryker Corporation

Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.

  • 4 riesgos, 6 oportunidades y 2 señales de alerta — cada uno con su fuente
  • Más de 100 métricas financieras con gráficos y comparativas
  • Resúmenes completos de noticias con enlaces a las fuentes
  • Equipo directivo y remuneración
  • Exportación a PDF para leer sin conexión
Desbloquea los 12 hallazgos3 informes gratis · sin tarjeta

III · Empresas similares

También te puede interesar

Same sector · Healthcare or comparable health

¿La añades a tu lista?

Read three companies free. Sin tarjeta.

Consigue 3 informes gratis